Blogs for category: Prescription RX

TCSIG Winter 2022 Update: Rate Changes, Healthcare Enhancements, and More

TCSIG Winter 2022 Update: Rate Changes, Healthcare Enhancements, and More

Explore TCSIG's Winter 2022 update, covering rate changes, healthcare enhancements, and wellness services for members.

Read More
January 2022 Prescription Changes

January 2022 Prescription Changes

Some members received letters from ProAct indicating changes required in their prescriptions however TCSIG worked with ProAct to grandfather prescriptions that were affected by the changes.

Read More
TCSIG Spring 2021 Wellness Center and Employee Benefits Update

TCSIG Spring 2021 Wellness Center and Employee Benefits Update

Stay informed about TCSIG's latest wellness and benefits offerings, including medical, dental, vision, prescription RX, and mental health services, along with updates on governance and more.

Read More
TCSIG Newsletter Highlights - March/April 2018

TCSIG Newsletter Highlights - March/April 2018

Dive into the March/April 2018 edition of the TCSIG Newsletter featuring wellness initiatives, the Bluebook Challenge, special education liability webinars, and more.

Read More
TCSIG Newsletter - January/February 2018 Issue

TCSIG Newsletter - January/February 2018 Issue

Stay informed with the latest updates from Tri County Schools Insurance Group in the January/February 2018 newsletter.

Read More
NEW PHARMACY BENEFITS MANAGER: INGENIO RX

NEW PHARMACY BENEFITS MANAGER: INGENIO RX

Pharmacy is an important part of your health benefits. Starting July 1, 2022, Ingenio Rx will manage your prescription drug coverage. Please watch the mail at the end of June for your new ID card. You will need to present this card when you use your pharmacy benefits.

Read More
PHARMACY BENEFITS MANAGER NAME CHANGE

PHARMACY BENEFITS MANAGER NAME CHANGE

Starting January 01, 2023, Ingenio Rx will be changing their name to Carelon RX. This will not affect your pharmacy coverage. If you have questions, please call us at (530) 822-5299.

Read More